Autoantibodies against corneal epithelium antigens are frequently found in patients with corneal diseases, but also in patients with uveitis. To investigate whether these autoantibodies play a primary role in the pathogenesis of corneal disease we studied the distribution of a 54 kD corneal antigen (isolated in a previous study) within the eye. Animal experiments were performed to determine the accessibility of this antigen by its corresponding antibody. Immunohistochemistry showed that the 54 kD corneal antigen was abundantly present in the rat corneal and conjunctival epithelium. A high concentration of this antigen was seen just above the nuclei in the basal cell layer of the corneal epithelium. The antigen could also be detected in the keratocytes of the corneal stroma, the corneal endothelium and the lens epithelium. The 54 kD corneal antigen was not detected in other parts of the eye, nor could it be found in the rat liver, kidney, spleen, lung or skeletal muscle. Incubation of intact rat eyes with antiserum against the 54 kD corneal antigen in vitro, resulted in a weak binding of immunoglobulins to the corneal surface epithelium cells. Passive transfer experiments, whereby rats received an intravenous injection of antiserum against the 54 kD corneal antigen resulted in a weak deposition of immunoglobulins in the corneal stroma and sclera. However, no antibodies were bound to the corneal epithelium. These observations show that although antibody production to corneal epithelium antigens is easily triggered, these antibodies do not reach the corneal epithelium.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/02713688709025203 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pediatric blepharokeratoconjunctivitis: A challenging ocular surface disease.
Surv Ophthalmol
January 2025
Tecnologico de Monterrey, School of Medicine and Health Sciences, Institute of Ophthalmology and Visual Sciences, Monterrey, Mexico.
Pediatric blepharokeratoconjunctivitis (PBKC) is a chronic and recurrent ocular surface inflammatory disorder affecting children in early life. It is frequently under- or late- diagnosed, representing a potential cause of severe visual morbidity worldwide. An expert panel consensus recently agreed on its definition and proposed diagnostic criteria for suspected and definitive PBKC to reduce confusion and avoid varied terminology previously used in the literature, improving early and precise diagnosis.
View Article and Find Full Text PDFS100A8/A9 Promotes Dendritic Cell-Mediated Th17 Cell Response in Sjögren's Dry Eye Disease by Regulating the Acod1/STAT3 Pathway.
Invest Ophthalmol Vis Sci
January 2025
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.
Purpose: To investigate the role of S100A8/A9 in the pathogenesis of Sjögren's dry eye disease (SjDED) and explore its potential mechanism of action.
Methods: S100A8/A9 expression was determined by western blot and quantitative real-time polymerase chain reaction (qRT-PCR). Tear secretion, corneal fluorescein staining, and hematoxylin and eosin staining were used to evaluate the effect of paquinimod, a S100A8/A9 inhibitor, on dry eye disease in nonobese diabetic (NOD) mice.
Efficacy of corneal squamous cell carcinoma antigen-1 in early infancy in predicting atopic dermatitis and food allergy: A prospective study.
Allergol Int
December 2024
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Background: Identification of predictive biomarkers is crucial for formulating preventive interventions and halting the progression of atopic march. Although controversial, the use of accessible markers to predict or detect early onset of atopic diseases is highly desirable. Therefore, this study aimed to investigate whether corneal squamous cell carcinoma antigen-1 (SCCA1) collected from infants can predict the development of atopic dermatitis and food allergy.
View Article and Find Full Text PDFCaffeine's protective role in dry eye disease and meibomian gland dysfunction: insights from clinical and experimental models.
Int Immunopharmacol
January 2025
Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address:
Purpose: Inflammation and apoptosis contribute to the development of dry eye disease (DED) and meibomian gland dysfunction (MGD). This study aimed to investigate the effect of caffeine on the ocular surface and tear inflammatory cytokines through clinical, in vivo, and in vitro experiments.
Methods: In the clinical study, comprehensive ophthalmic examinations of participants in the control and the caffeine groups were compared, including ocular surface and tears inflammatory cytokines.
Characterization of the Ocular Phenotype in a Col4a3 Knockout Mouse Model of Alport Syndrome.
Invest Ophthalmol Vis Sci
December 2024
Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States.
Purpose: Alport syndrome (AS) is a genetic condition caused by a dysfunctional collagen (IV) α3α4α5 heterotrimer, leading to basement membrane instability and, ultimately, abnormalities in the kidney, inner ear, and eyes. This study aimed to characterize ocular pathology of AS by focusing on inflammatory and fibrotic markers.
Methods: Col4a3tm1Dec knockout (KO) mice eyes were evaluated for the localization of collagen (IV) α3 and collagen (IV) α4, then stained for transforming growth factor-β1 (TGF-β1), TGF-β2, connective tissue growth factor (CTGF), and β-catenin.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!